Drug recall

Distributed by: DocRx, Methylprednisolone Tablets, USP 4 mg, Rx, 21 Count Blister, NDC: 69306-004-21…

FDA recall event 87548 · Class III · Asclemed USA Inc. dba Enovachem Pharmaceuticals

Key facts

Event ID 87548
Recall numbers D-0330-2021
Recalling firm Asclemed USA Inc. dba Enovachem Pharmaceuticals
Product type Drugs
Products Distributed by: DocRx, Methylprednisolone Tablets, USP 4 mg, Rx, 21 Count Blister, NDC: 69306-004-21, Relabeled by: Enovachem Pharmaceuticals 379 Van Ness Ave. Suite 1403-1406, Torrance, CA 90501…
Classification Class III
Status Ongoing
Voluntary or mandated Voluntary: Firm Initiated
Reason for recall Labeling: Illegible label: Manufacturer received complaint of mis-alignment print of the printed dosing instructions on the blister card.
Initiation date Mar 19, 2021
Report date Apr 21, 2021
City Torrance
State CA
Country United States
FEI number 3001452204

At a glance

  • 1–9 Products in this recall
  • 1–9 FDA inspections of this firm (FEI)

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA drug and product recalls

FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.

Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date:

Browse all FDA drug and product recalls